US EditionNine of the largest pharma companies ink deals with Trump to lower drug prices
Fourteen of seventeen top drugmakers have agreed to cut Medicaid drug prices and sell discounted medicines, with $150 billion committed to U.S. manufacturing and research investments.
- President Donald Trump announced that nine major pharmaceutical companies agreed to join his "most favored nation" pricing policy, bringing down the price of prescription drugs for Medicare and Medicaid recipients.
- The deal ensures that drugs will be sold at reduced prices, with many sold at the same price that they're sold at overseas, which will be purchased through the TrumpRx platform due to launch in January.
- The new agreement will reduce the cost of medications used to treat a variety of chronic and costly conditions, and state Medicaid programs will be able to access the medications at the prices agreed upon.
250 Articles
250 Articles
U.S. President Donald Trump announced Friday agreements with nine other pharmaceutical companies to reduce the prices of some drugs, an action that is part of his efforts to match the cost of certain drugs with the lowest prices paid in other countries.With Friday's agreement, which includes Bristol Myers Squibb, Genentech, Boehringer Ingelheim, Sanofi, Novartis, Merck, Gilead, GSK and Amgem, 14 major pharmaceutical companies have already agreed…
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - AbbVie (NYSE:ABBV), Amgen (NASDAQ:AMGN)
Trump and nine major pharmaceutical companies struck deals to lower drug prices for cash payers and Medicaid, with over $150 billion pledged for U.S. R&D and manufacturing.
Drugmakers cut prices on most drugs sold to the US Medicaid program
US president Donald Trump and nine major pharmaceutical companies announced deals on Friday that will slash the prices of their medicines for the government's Medicaid program and for cash payers, in his latest bid to align US costs with those in other wealthy nations.
Big Pharma Takes a Knee - Agreement to Deliver Low-Cost Pharmaceuticals to America
The look on the faces of the CEOs representing some of the biggest drug manufacturers tells the story. Against the stern backdrop of collapsed resistance, President Trump announces the results of his “most favored nation” policy demand toward major pharmaceutical companies. President Trump delivers remarks from the oval office, outlining the result of demanding pharmaceutical […]
Coverage Details
Bias Distribution
- 65% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
